STERLING HAHN: Open Payments
NPI 1306334941 · HENDERSON, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$139 in 7 payments from 6 companies in 2025. Trend: 2023 $0 · 2024 $90 · 2025 $139
Food & beverage: $139
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 2 | $39 |
| Almatica Pharma LLC | 1 | $23 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $22 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $21 |
| Bausch Health US, LLC | 1 | $19 |
| Lundbeck LLC | 1 | $15 |
Products named: ABILIFY ASIMTUFII, LOREEV XR, TRINTELLIX, CAPLYTA, APLENZIN, REXULTI.
Industry payments across NV — which companies pay providers there.
